Molecule Information
General Information of the Molecule (ID: Mol00746)
Name |
AAC(6')-Ib family aminoglycoside 6'-N-acetyltransferase (AAC6IB)
,Vibrio cholerae
|
||||
---|---|---|---|---|---|
Synonyms |
aac(6')-Ib; EYB64_20715; 6')-Ib family aminoglycoside 6'-N-acetyltransferase
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
aac(6')-Ib
|
||||
Sequence |
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT RSVA Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
ADTT: Aberration of the Drug's Therapeutic Target
EADR: Epigenetic Alteration of DNA, RNA or Protein
IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Drug
Approved Drug(s)
6 drug(s) in total
Chloramphenicol
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Vibrio cholerae infection | [1] | |||
Resistant Disease | Vibrio cholerae infection [ICD-11: 1A00.0] | |||
Resistant Drug | Chloramphenicol | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Vibrio cholerae PL107b | 666 | ||
Experiment for Molecule Alteration |
PCR and DNA sequencing assay | |||
Experiment for Drug Resistance |
Commercial antimicrobial discs assay | |||
Mechanism Description | The expression of aac(6')-Ib lead to drug resistance. |
Framycetin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Vibrio cholerae infection | [1] | |||
Resistant Disease | Vibrio cholerae infection [ICD-11: 1A00.0] | |||
Resistant Drug | Framycetin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Vibrio cholerae PL107b | 666 | ||
Experiment for Molecule Alteration |
PCR and DNA sequencing assay | |||
Experiment for Drug Resistance |
Commercial antimicrobial discs assay | |||
Mechanism Description | The expression of aac(6')-Ib lead to drug resistance. |
Furazolidone
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Vibrio cholerae infection | [1] | |||
Resistant Disease | Vibrio cholerae infection [ICD-11: 1A00.0] | |||
Resistant Drug | Furazolidone | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Vibrio cholerae PL107b | 666 | ||
Experiment for Molecule Alteration |
PCR and DNA sequencing assay | |||
Experiment for Drug Resistance |
Commercial antimicrobial discs assay | |||
Mechanism Description | The expression of aac(6')-Ib lead to drug resistance. |
Gentamicin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Vibrio cholerae infection | [1] | |||
Resistant Disease | Vibrio cholerae infection [ICD-11: 1A00.0] | |||
Resistant Drug | Gentamicin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Vibrio cholerae PL107b | 666 | ||
Experiment for Molecule Alteration |
PCR and DNA sequencing assay | |||
Experiment for Drug Resistance |
Commercial antimicrobial discs assay | |||
Mechanism Description | The expression of aac(6')-Ib lead to drug resistance. |
Streptomycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Vibrio cholerae infection | [1] | |||
Resistant Disease | Vibrio cholerae infection [ICD-11: 1A00.0] | |||
Resistant Drug | Streptomycin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Vibrio cholerae PL107b | 666 | ||
Experiment for Molecule Alteration |
PCR and DNA sequencing assay | |||
Experiment for Drug Resistance |
Commercial antimicrobial discs assay | |||
Mechanism Description | The expression of aac(6')-Ib lead to drug resistance. |
Trimethoprim
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Vibrio cholerae infection | [1] | |||
Resistant Disease | Vibrio cholerae infection [ICD-11: 1A00.0] | |||
Resistant Drug | Trimethoprim | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Vibrio cholerae PL107b | 666 | ||
Experiment for Molecule Alteration |
PCR and DNA sequencing assay | |||
Experiment for Drug Resistance |
Commercial antimicrobial discs assay | |||
Mechanism Description | The expression of aac(6')-Ib lead to drug resistance. |
Investigative Drug(s)
1 drug(s) in total
Sulfamethizole/Sulfadiazine
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Vibrio cholerae infection | [1] | |||
Resistant Disease | Vibrio cholerae infection [ICD-11: 1A00.0] | |||
Resistant Drug | Sulfamethizole/Sulfadiazine | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Vibrio cholerae PL107b | 666 | ||
Experiment for Molecule Alteration |
PCR and DNA sequencing assay | |||
Experiment for Drug Resistance |
Commercial antimicrobial discs assay | |||
Mechanism Description | The expression of aac(6')-Ib lead to drug resistance. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.